Makers of generic Zantac halt distribution amid cancer concerns
Makers of generic Zantac halt distribution amid cancer concerns

Makers of generic Zantac halt distribution amid cancer concerns

After the U.S. Food and Drug Administration found traces of a cancer-causing chemical in Zantac, the makers of the generic version of the heartburn drug halted worldwide distribution until further notice.

Latest LiveNOW Stories

From the Archives

Consumer & Money

Science & Tech

Police Chases

Weather Across the Country